IN RE CORMEDIX INC. DERIVATIVE LITIGATION

Track this case

Case Number:

2:21-cv-18493

Court:

New Jersey

Nature of Suit:

Stockholders Suits

Multi Party Litigation:

Derivative Litigation

Judge:

Julien Xavier Neals

Firms

Companies

Sectors & Industries:

  1. January 20, 2026

    CorMedix Investors Seek First OK Of Governance Reform Deal

    Investors in CorMedix Inc. have told a New Jersey federal judge that company directors have agreed to implement several corporate governance reforms to resolve a consolidated shareholder derivative lawsuit accusing the executives of making misleading statements about delays in the regulatory approval of the company's lead drug candidate.

  2. October 13, 2021

    Investor Says Biotech Co. Hid Issues Leading To Delays

    A CorMedix Inc. investor launched a derivative shareholder lawsuit Wednesday, claiming that the biopharmaceutical firm's share value plummeted when the public learned that previously undisclosed manufacturing issues were delaying regulatory approval of its antibacterial product candidate.